RightFit
RecruitingPhase not listed

Lung Cancer Biomarkers and Screening

NYU Lung Cancer Biomarker Center

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
50 Years and older
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: CT scans, Questionnaires, Biopsies

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Group 1 (screening cohort): Participants complete a questionnaire and undergo pulmonary function testing, multidetector chest CT scan, sputum induction, and phlebotomy."
  • "Group 2 (rule-out lung cancer): Participants complete the same questionnaire and undergo the same tests and scans as in group 1."
  • "Some participants may undergo fiberoptic bronchoscopy based upon CT scan results with transbronchial or endobronchial biopsies."
  • "Tissue samples are collected from surgery or biopsy."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study looks at biomarkers, or signs in the body, to help screen for lung cancer. It is for people at high or low risk of lung cancer and people sent for testing of suspicious lung spots.

RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • For the screening group: be at high or low risk for lung cancer.
  • For the screening group: have smoked at least 20 pack-years, such as 1 pack a day for 20 years. People with less smoking history can join if they are age 50 or older.
  • People in the screening group may join with or without contact with asbestos at work.
  • For the lung spot testing group: have been sent for testing of suspicious lung nodules (spots), with a diagnosis of lung cancer or nodules that are not cancer.

Who can't join

  • Being pregnant.
  • Having had cancer before, except nonmelanoma skin cancer (skin cancer other than melanoma).

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

DISEASE CHARACTERISTICS: * Screening Cohort * At high- or low-risk for lung cancer * Smoking history ≥ 20 pack years\* * With or without workplace exposure to asbestos * NOTE: \* Participants with \< 20 pack years of smoking are eligible if 50 years of age or older * Rule-Out Lung cancer group * Referred for evaluation of suspicious nodules with 1 of the following diagnoses: * Lung cancer * Nonmalignant nodules (control group) PATIENT CHARACTERISTICS: * Not pregnant * No prior malignancy except nonmelanoma skin cancer PRIOR CONCURRENT THERAPY: * Not specified

Study sites (1)

NY